Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease.

Zhou Y, Qin S, Sun M, Tang L, Yan X, Kim TK, Caballero J, Glusman G, Brunkow ME, Soloski MJ, Rebman AW, Scavarda C, Cooper D, Omenn GS, Moritz RL, Wormser GP, Price ND, Aucott JN, Hood L.

J Proteome Res. 2019 Nov 1. doi: 10.1021/acs.jproteome.9b00569. [Epub ahead of print]

PMID:
31618575
2.

Peridomestic and community-wide landscape risk factors for Lyme disease across a range of community contexts in Pennsylvania.

Moon KA, Pollak J, Poulsen MN, Hirsch AG, DeWalle J, Heaney CD, Aucott JN, Schwartz BS.

Environ Res. 2019 Nov;178:108649. doi: 10.1016/j.envres.2019.108649. Epub 2019 Aug 13.

PMID:
31465993
3.

Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.

Mosel MR, Carolan HE, Rebman AW, Castro S, Massire C, Ecker DJ, Soloski MJ, Aucott JN, Eshoo MW.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00237-19. doi: 10.1128/AAC.00237-19. Print 2019 Jul.

PMID:
31036693
4.

Automated detection of erythema migrans and other confounding skin lesions via deep learning.

Burlina PM, Joshi NJ, Ng E, Billings SD, Rebman AW, Aucott JN.

Comput Biol Med. 2019 Feb;105:151-156. doi: 10.1016/j.compbiomed.2018.12.007. Epub 2018 Dec 18.

PMID:
30654165
5.

Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET.

Coughlin JM, Yang T, Rebman AW, Bechtold KT, Du Y, Mathews WB, Lesniak WG, Mihm EA, Frey SM, Marshall ES, Rosenthal HB, Reekie TA, Kassiou M, Dannals RF, Soloski MJ, Aucott JN, Pomper MG.

J Neuroinflammation. 2018 Dec 19;15(1):346. doi: 10.1186/s12974-018-1381-4.

6.

Epidemiology of Lyme disease in Pennsylvania 2006-2014 using electronic health records.

Moon KA, Pollak J, Hirsch AG, Aucott JN, Nordberg C, Heaney CD, Schwartz BS.

Ticks Tick Borne Dis. 2019 Feb;10(2):241-250. doi: 10.1016/j.ttbdis.2018.10.010. Epub 2018 Oct 26.

PMID:
30420251
7.

Robust B Cell Responses Predict Rapid Resolution of Lyme Disease.

Blum LK, Adamska JZ, Martin DS, Rebman AW, Elliott SE, Cao RRL, Embers ME, Aucott JN, Soloski MJ, Robinson WH.

Front Immunol. 2018 Jul 18;9:1634. doi: 10.3389/fimmu.2018.01634. eCollection 2018.

8.

Incidence of Lyme Disease Diagnosis in a Maryland Medicaid Population, 2004-2011.

Rebman AW, Wang L, Yang T, Marsteller JA, Murphy SME, Uriyo M, Mihm EA, Weinstein ER, Fagan P, Aucott JN.

Am J Epidemiol. 2018 Oct 1;187(10):2202-2209. doi: 10.1093/aje/kwy133.

PMID:
29955850
9.

Cognitive Decline in Post-treatment Lyme Disease Syndrome.

Touradji P, Aucott JN, Yang T, Rebman AW, Bechtold KT.

Arch Clin Neuropsychol. 2019 Jun 1;34(4):455-465. doi: 10.1093/arclin/acy051.

PMID:
29945190
10.

Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland.

Weinstein ER, Rebman AW, Aucott JN, Johnson-Greene D, Bechtold KT.

Sleep. 2018 May 1;41(5). doi: 10.1093/sleep/zsy035.

PMID:
29452400
11.

The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.

Rebman AW, Bechtold KT, Yang T, Mihm EA, Soloski MJ, Novak CB, Aucott JN.

Front Med (Lausanne). 2017 Dec 14;4:224. doi: 10.3389/fmed.2017.00224. eCollection 2017.

12.

Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time.

Bechtold KT, Rebman AW, Crowder LA, Johnson-Greene D, Aucott JN.

Arch Clin Neuropsychol. 2017 Mar 1;32(2):129-141. doi: 10.1093/arclin/acw098.

PMID:
28365751
13.

CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Bechtold KT.

Clin Vaccine Immunol. 2016 Sep 6;23(9):757-66. doi: 10.1128/CVI.00071-16. Print 2016 Sep.

14.

Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease.

Bouquet J, Soloski MJ, Swei A, Cheadle C, Federman S, Billaud JN, Rebman AW, Kabre B, Halpert R, Boorgula M, Aucott JN, Chiu CY.

MBio. 2016 Feb 12;7(1):e00100-16. doi: 10.1128/mBio.00100-16.

15.

Living in Limbo: Contested Narratives of Patients With Chronic Symptoms Following Lyme Disease.

Rebman AW, Aucott JN, Weinstein ER, Bechtold KT, Smith KC, Leonard L.

Qual Health Res. 2017 Mar;27(4):534-546. doi: 10.1177/1049732315619380. Epub 2016 Jul 10.

PMID:
26631681
16.

Quantification of Borrelia burgdorferi Membrane Proteins in Human Serum: A New Concept for Detection of Bacterial Infection.

Cheung CS, Anderson KW, Benitez KY, Soloski MJ, Aucott JN, Phinney KW, Turko IV.

Anal Chem. 2015 Nov 17;87(22):11383-8. doi: 10.1021/acs.analchem.5b02803. Epub 2015 Nov 4.

17.

Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

Lahey LJ, Panas MW, Mao R, Delanoy M, Flanagan JJ, Binder SR, Rebman AW, Montoya JG, Soloski MJ, Steere AC, Dattwyler RJ, Arnaboldi PM, Aucott JN, Robinson WH.

J Clin Microbiol. 2015 Dec;53(12):3834-41. doi: 10.1128/JCM.02111-15. Epub 2015 Oct 7.

18.

Posttreatment Lyme disease syndrome.

Aucott JN.

Infect Dis Clin North Am. 2015 Jun;29(2):309-23. doi: 10.1016/j.idc.2015.02.012. Review.

PMID:
25999226
19.

Lyme disease and post-treatment Lyme disease syndrome: the neglected disease in our own backyard.

Crowder LA, Yedlin VA, Weinstein ER, Kortte KB, Aucott JN.

Public Health. 2014 Sep;128(9):784-91. doi: 10.1016/j.puhe.2014.06.016. Epub 2014 Sep 9.

PMID:
25213101
20.

Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients.

Rebman AW, Crowder LA, Kirkpatrick A, Aucott JN.

Clin Rheumatol. 2015 Mar;34(3):585-9. doi: 10.1007/s10067-014-2706-z. Epub 2014 Jun 13.

PMID:
24924604
21.

Serum inflammatory mediators as markers of human Lyme disease activity.

Soloski MJ, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Aucott JN.

PLoS One. 2014 Apr 16;9(4):e93243. doi: 10.1371/journal.pone.0093243. eCollection 2014.

22.

Atypical erythema migrans in patients with PCR-positive Lyme disease.

Schutzer SE, Berger BW, Krueger JG, Eshoo MW, Ecker DJ, Aucott JN.

Emerg Infect Dis. 2013 May;19(5):815-7. doi: 10.3201/eid1905.120796. No abstract available.

23.

Development of a foundation for a case definition of post-treatment Lyme disease syndrome.

Aucott JN, Crowder LA, Kortte KB.

Int J Infect Dis. 2013 Jun;17(6):e443-9. doi: 10.1016/j.ijid.2013.01.008. Epub 2013 Feb 23.

24.

Bull's-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans.

Aucott JN, Crowder LA, Yedlin V, Kortte KB.

Dermatol Res Pract. 2012;2012:451727. doi: 10.1155/2012/451727. Epub 2012 Oct 24.

25.
26.

Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease.

Eshoo MW, Crowder CC, Rebman AW, Rounds MA, Matthews HE, Picuri JM, Soloski MJ, Ecker DJ, Schutzer SE, Aucott JN.

PLoS One. 2012;7(5):e36825. doi: 10.1371/journal.pone.0036825. Epub 2012 May 8.

27.

Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?

Aucott JN, Rebman AW, Crowder LA, Kortte KB.

Qual Life Res. 2013 Feb;22(1):75-84.

28.

Misdiagnosis of early Lyme disease as the summer flu.

Aucott JN, Seifter A.

Orthop Rev (Pavia). 2011;3(2):e14. doi: 10.4081/or.2011.e14. Epub 2011 Jun 29.

29.

Sex differences in the clinical and serologic presentation of early Lyme disease: Results from a retrospective review.

Schwarzwalder A, Schneider MF, Lydecker A, Aucott JN.

Gend Med. 2010 Aug;7(4):320-9. doi: 10.1016/j.genm.2010.08.002.

PMID:
20869632
30.

Unusual presentation of Lyme disease: Horner syndrome with negative serology.

Morrison C, Seifter A, Aucott JN.

J Am Board Fam Med. 2009 Mar-Apr;22(2):219-22. doi: 10.3122/jabfm.2009.02.080130.

31.

Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease.

Coulter P, Lema C, Flayhart D, Linhardt AS, Aucott JN, Auwaerter PG, Dumler JS.

J Clin Microbiol. 2005 Oct;43(10):5080-4. Erratum in: J Clin Microbiol. 2007 Jan;45(1):277.

32.
33.

The problem of retaining clinical teachers in academic medicine.

Papp KK, Aucott JN, Aron DC.

Perspect Biol Med. 2001 Summer;44(3):402-13. No abstract available.

PMID:
11482009
34.

Distribution of research awards from the National Institutes of Health among medical schools.

Aron DC, Aucott JN, Papp KK.

N Engl J Med. 2000 Jun 8;342(23):1754; author reply 1754-5. No abstract available.

PMID:
10858096
35.

Clinician-educators in academic medical centers.

Aron DC, Aucott JN.

N Engl J Med. 2000 Jan 13;342(2):138; author reply 139. No abstract available.

PMID:
10636760
36.

Attending-physician role models.

Aron DC, Lash R, Aucott JN.

N Engl J Med. 1999 May 20;340(20):1598; author reply 1599. No abstract available.

PMID:
10336369
37.

Implementation of local guidelines for cost-effective management of hypertension. A trial of the firm system.

Aucott JN, Pelecanos E, Dombrowski R, Fuehrer SM, Laich J, Aron DC.

J Gen Intern Med. 1996 Mar;11(3):139-46.

PMID:
8667090
38.

Sarcoid myopathy in a patient with human immunodeficiency virus infection.

Granieri J, Wisnieski JJ, Graham RC, Smith H, Gogate P, Aucott JN.

South Med J. 1995 May;88(5):591-5.

PMID:
7732455
39.

Interdisciplinary integration for quality improvement: the Cleveland Veterans Affairs Medical Center Firm System.

Aucott JN, Pelecanos E, Bailey AJ, Shupe TC, Romeo JH, Ravdin JI, Aron DC.

Jt Comm J Qual Improv. 1995 Apr;21(4):179-90.

PMID:
7780532
40.

Glucocorticoids and infection.

Aucott JN.

Endocrinol Metab Clin North Am. 1994 Sep;23(3):655-70. Review.

PMID:
7805661
41.

Developing guidelines for local use: algorithms for cost-efficient outpatient management of cardiovascular disorders in a VA Medical Center.

Aucott JN, Taylor AL, Wright JT Jr, Ganz MB, Landefeld CS, Pelecanos EI, Carrol AM, Dombrowski RC, van Why KJ, Lederman R, et al.

Jt Comm J Qual Improv. 1994 Jan;20(1):17-32.

PMID:
8173643
42.

Amebiasis and "nonpathogenic" intestinal protozoa.

Aucott JN, Ravdin JI.

Infect Dis Clin North Am. 1993 Sep;7(3):467-85. Review.

PMID:
8254155
43.

Management of gallstones in diabetic patients.

Aucott JN, Cooper GS, Bloom AD, Aron DC.

Arch Intern Med. 1993 May 10;153(9):1053-8. Review.

PMID:
8481073
44.
45.

Protease priming of neutrophil superoxide production. Effects on membrane lipid order and lateral mobility.

Kusner DJ, Aucott JN, Franceschi D, Sarasua MM, Spagnuolo PJ, King CH.

J Biol Chem. 1991 Sep 5;266(25):16465-71.

46.

Invasive infection with Saccharomyces cerevisiae: report of three cases and review.

Aucott JN, Fayen J, Grossnicklas H, Morrissey A, Lederman MM, Salata RA.

Rev Infect Dis. 1990 May-Jun;12(3):406-11. Review.

PMID:
2193348

Supplemental Content

Loading ...
Support Center